Author

Zhen Wang

Chinese Academy of SciencesORCID 0000-0001-8762-6089Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Zhen Wang12 papers · Chinese Academy of Sciences

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Arul M. ChinnaiyaniD· 3 shared Ke DingiD· 3 shared Abhijit ParoliaiD· 2 shared Lanbo XiaoiD· 2 shared Lianchao Liu· 2 shared Rahul MannaniD· 2 shared Somnath MahapatraiD· 2 shared Tongchen He· 2 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

Arul M. ChinnaiyanORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologyJournal of Medicinal ChemistryPeer-reviewedOct 4, 2026

Single-Atom Modification Enables Reversal of Degradation Selectivity between NSD2 and GSPT1

Weizhong Shen, Yihan Liu, Lianchao Liu…·Ke Ding

This study modifies a molecule to create two variants with different target selectivity, showing how small structural changes can control degradation activity.

DOI 10.1021/acs.jmedchem.6c01678

experimental assaydrug response / drug discovery

𝕏 PostBluesky

Cancer BiologyNaturePeer-reviewedApr 23, 2025

Targeting PIKfyve-driven lipid homeostasis as a metabolic vulnerability in pancreatic cancer

Caleb Cheng, Jing Hu, Rahul Mannan…·Arul M. Chinnaiyan

This study identifies PIKfyve as a targetable vulnerability in pancreatic cancer by showing its role in lipid metabolism and synthetic lethality with KRAS-MAPK inhibitors.

79 citationstop 1%

𝕏 PostBluesky

Cancer BiologyNature GeneticsPeer-reviewedSep 9, 2024

NSD2 is a requisite subunit of the AR/FOXA1 neo-enhanceosome in promoting prostate tumorigenesis

Abhijit Parolia, Sanjana Eyunni, Brijesh Kumar Verma…·Irfan Ahmed Asangani

This study identifies NSD2 as a critical component of the AR neo-enhanceosome in prostate cancer, showing its role in AR enhancer circuitry and tumor progression.

45 citationstop 2%

𝕏 PostBluesky